Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
They are not interchangeable, and the choice depends on symptoms, blood results, and clinical judgement
To view a copy of this license, visit About this article Cite this article Xie, N., Zhang, L., Gao, W
Peptides are short chains of amino acids naturally occurring in the body that play many important roles 1 Peptide synthesis in vivo | Friedberg et al
No evidence-based guidelines regarding the use of B 12 testing in people with suspected B 12 deficiency
Stay informed, verify quality, and prioritize transparency when buying peptides
